Then we examined COX7B by immunohistochemistry in a cohort of 16 bladder cancer samples from patients who underwent neoadjuvant CDDP‐based chemotherapy (NAC) before surgery (Figure 4B, Table S6). The gene discussed is COX7B; the disease is urinary bladder carcinoma.